Si-bone, inc. (SIBN)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities
Net loss

-12,772

-9,098

-11,306

-8,654

-9,345

-5,313

-4,792

-3,147

-4,201

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

2,622

1,868

1,911

1,814

1,871

1,231

327

362

392

Depreciation and amortization

249

204

175

202

193

186

180

188

168

Bad debts expense

192

-

-

-

0

-

-

-

-

Accretion on marketable securities

25

125

348

461

479

209

0

0

0

Amortization of debt issuance costs

65

-

-

-

65

-

-

-

-

Amortization of debt discount

-

-

-

-

-

-

-

65

65

Change in fair value of redeemable convertible preferred stock warrants

-

-

-

-

-

145

457

145

79

Loss on sale and disposal of property and equipment

0

-19

-54

-1

-97

43

-47

-8

-40

Changes in operating assets and liabilities:
Accounts receivable

-2,207

1,853

467

1,003

-87

1,382

-160

39

-233

Inventory

256

530

483

927

165

301

138

99

221

Prepaid expenses and other assets

-581

909

-292

-269

167

1,247

-258

-518

281

Accounts payable

76

-143

188

-113

451

1,135

-422

-544

82

Accrued liabilities and other

-2,294

1,469

2,800

411

314

-584

1,330

1,281

-767

Net cash used in operating activities

-9,355

-9,033

-7,120

-8,396

-7,078

-6,317

-2,529

-1,262

-4,411

Cash flows from investing activities
Maturities of marketable securities

21,000

42,700

33,500

66,000

17,600

0

0

0

0

Purchases of marketable securities

16,777

36,319

25,029

59,775

22,741

96,883

0

0

0

Purchases of property and equipment

884

806

746

481

412

165

62

497

218

Net cash provided by (used in) investing activities

3,339

5,575

7,725

5,744

-5,553

-97,048

-62

-497

-218

Cash flows from financing activities
Proceeds from follow-on public offering, net of underwriting discounts, commissions and offering costs

62,978

-

-

-

0

-

-

-

-

Proceeds from the exercise of stock options

174

312

611

442

125

699

707

188

20

Net cash provided by financing activities

63,152

1,252

573

1,538

125

114,523

419

188

20

Effect of exchange rate changes on cash and cash equivalents

-3

27

-60

49

-53

-42

-57

12

-7

Net decrease in cash and cash equivalents

57,133

-2,179

1,118

-1,065

-12,559

11,116

-2,229

-1,559

-4,616

Cash and cash equivalents at
Supplemental disclosure of non-cash information
Vesting of early exercised stock options

27

36

39

56

66

75

36

10

18

Purchases of property and equipment included in accounts payable and accrued liabilities

52

344

-26

-83

140

47

-62

97

0

Public offering costs included in accounts payable

0

-

-

-

167

-

-

-

0